DaVita Inc. (NYSE:DVA) Shares Acquired by PGGM Investments

PGGM Investments boosted its holdings in DaVita Inc. (NYSE:DVA) by 57.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,293 shares of the company’s stock after acquiring an additional 4,106 shares during the period. PGGM Investments’ holdings in DaVita were worth $1,689,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in DVA. MML Investors Services LLC lifted its stake in shares of DaVita by 1.3% in the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after purchasing an additional 68 shares during the last quarter. Exchange Traded Concepts LLC raised its holdings in DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after buying an additional 68 shares during the period. Impact Partnership Wealth LLC lifted its position in DaVita by 3.7% in the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after buying an additional 70 shares during the last quarter. Contravisory Investment Management Inc. lifted its position in DaVita by 1.2% in the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after buying an additional 73 shares during the last quarter. Finally, Nilsine Partners LLC boosted its stake in DaVita by 0.8% during the fourth quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock worth $1,669,000 after buying an additional 92 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Price Performance

DaVita stock opened at $141.23 on Friday. The company’s 50 day moving average is $159.28 and its two-hundred day moving average is $157.79. The firm has a market cap of $11.30 billion, a PE ratio of 13.15, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60.

DaVita (NYSE:DVA) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on DVA shares. Barclays upped their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.